Tricuspid Isthmus Imaged by CARTOsound, Patients With Typical Atrial Flutter
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01113788|
Recruitment Status : Unknown
Verified April 2010 by Lawson Health Research Institute.
Recruitment status was: Recruiting
First Posted : April 30, 2010
Last Update Posted : April 30, 2010
The investigators propose a third hypothesis based on the anatomic observations made in pathological studies. The investigators hypothesize that the anatomic architecture determines the functional properties of the TV-IVC isthmus. As a result,
• Muscular bundles are preferential routes of conduction through the TV-IVC isthmus. The isthmus acts like a series of discreet conduction routes rather than as a sheet of tissue.
The muscular bundles form selective targets for ablation and therefore the entire anatomic line need not be ablated. This has direct implications for ablation of the isthmus.
|Condition or disease||Intervention/treatment|
|Atrial Flutter||Device: tricuspid isthmus imaging with Cartosound|
|Study Type :||Observational|
|Estimated Enrollment :||15 participants|
|Official Title:||Tricuspid Isthmus Architecture as Imaged by CARTOsound, Determines Ablation Times in Patients With Typical Atrial Flutter|
|Study Start Date :||March 2010|
|Estimated Primary Completion Date :||December 2010|
|Estimated Study Completion Date :||December 2010|
imaging with usual catheter/fluoroscopy, no cartosound
Device: tricuspid isthmus imaging with Cartosound
tricuspid isthmus imaging with Cartosound
Other Name: Cartosound
- observational including ablation lesion number, ablation time in minutes, fluoroscopic [ Time Frame: 12 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01113788
|Contact: Allan Skanes, MDemail@example.com|
|Contact: Cathy Bentleyfirstname.lastname@example.org|
|London Health Sciences Center||Recruiting|
|London, Ontario, Canada, N6A 5A5|
|Principal Investigator:||Allan Skanes, MD, FRCPC||London Health Sciences Centre|